Skip to content
10-K/A

Annual Report

DAY ONE BIOPHARMACEUTICALS, INC.

0001193125-26-161471

← back to feed
Filed
Apr 17, 2026 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Apr 15, 2026 103.33M sh
Net Income restated FY 2025 · Dec 31, 2025 −$107.32B
Net Income restated FY 2025 · Dec 31, 2024 −$95.5B
Net Income restated FY 2025 · Dec 31, 2023 −$188.92B
Net Income restated FY 2025 · Dec 31, 2022 −$142.18B
Net Income FY 2025 · Dec 31, 2021 −$72.75B